Surgical management of age-related macular degeneration

Canadian Journal of Ophthalmology

Volumn 40, Issue 3, 2005, Pages 341-351

  Conti, Stephen M ^a   Kertes, Peter J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Age factor; Choroidal neovascularization; Hemorrhage; Macular degeneration; Subretinal neovascularization; Surgery; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; BALANCED SALT SOLUTION; FIBRIN; FLUOROCARBON; MINERAL; PEGAPTANIB; VITAMIN;

CLINICAL TRIAL; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; NONHUMAN; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PROGNOSIS; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; RETINA MACULA TRANSLOCATION; RETINOTOMY; REVIEW; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITRECTOMY;

EID: 21744448796     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(05)80077-8     Document Type: Article

References (64)

1. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol 1978;85:28-34.
2. Klein R, Wang Q, Klein HE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
3. Bressler NM. Submacular surgery: Are randomized trials necessary? Arch Ophthalmol 1995;113:1557-60.
4. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-9.
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins G and H, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36.
6. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (IAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report no. 1 [published erratum appears in Arch Ophthalmol 2000; 118: 488]. Arch Ophthalmol 1999;117:1329-45.
7. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351: 2805-16.
8. de Juan E, Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-9.
9. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA. Surgical management of subfoveal choroidal neovascularizarion. Ophthalmology 1992;99:952-68.
10. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes. Ophthalmology 1992;99:969-76.
11. Lambert HM, Capone A Jr, Aaberg TM, Sternberg P Jr, Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1992;113:257-62.
12. Ibanez HR, Willams DF, Thomas MA, Ruby AJ, Meredith TA, Boniuk I, et al. Surgical management of submacular hemorrhage: A series of 47 consecutive cases. Arch Ophthalmol 1995;113:62-9.
13. Grossniklaus HE, Gass JDM. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998;126:59-69.
14. Grossniklaus HE, Green WR. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Arch Ophthalmol 1998;116:745-9.
15. Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg P Jr, Thomas MA; Submacular Surgery Trials Pilot Study Investigators. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes. SSTPS report no. 1. Am J Ophthalmol 2000;130:387-407.
16. Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp NM, Marsh MJ, et al; Submacular Surgery Trials (SST) Research Group. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology 2004;111:1967-80.
17. Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al; Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004;111:1993-2006.
18. Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-93.
19. Bennett AR, Folk JC, Blodi CF, Kugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol 1990;109:33-7.
20. Hartnett ME, Weiter JJ, Garsd A, Jalkh AE. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992;230:11-9.
21. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-34.
22. Borrillo JL, Sivalingam A, Martidis A, Federman JL. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 2003;121:58-61.
23. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762-73.
24. Toth CA, Morse LS, Hjelmeland LM, Landers MB 3rd. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 1991;109:723-9.
25. Wade EW, Flynn AW Jr, Losen KR, Blumenkranz MS, Nicholson DH. Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 1990;108:973-8.
26. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-68.
27. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yunsa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996;121:267-75.
28. Herriot WJ. Further experience in management of submacular hemorrhage with intravitreal t-PA. In: Proceedings of the 1997 update on macular surgery. San Francisco, Calif: American Academy of Ophthalmology; 1997. p. 82-4.
29. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237: 273-7.
30. Karlsson E, Carlsson J, Crafoord S, Jemt M, Martensson PA, Stenkula S. Tissue plasminogen activator and expanding gas intravitreally in treatment of submacular hemorrhage. Acta Ophthalmol Scand 1999;77:119. [abstract]
31. Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-6.
32. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol 2001;119: 28-32.
33. Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 2001;108:1485-92.
34. Ohji M, Saito Y, Hayashi A, Lewis J, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-32.
35. Daneshvar H, Kertes PJ, Leonard BC, Peyman GA. Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study. Can J Ophthalmol 1999;34:385-8.
36. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am Ophthalmol 1999;128:739-46.
37. Johnson MW, Olsen KR, Hernandez E, Irvine WD, Johnson RN. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990; 108:259-63.
38. Haupert CL, McCuen BW 2nd, Jaffe GJ, Steuer ER, Cox TA, Toth CA, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol 2001;131:208-15.
39. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 2004;111:1201-8.
40. Yepremyan M, Kapusta M. The rate of iatrogenic retinal breaks in 25-gauge system pars plana vitrectomy. In: Proceedings of the American Society of Retina Specialists 22nd Annual Meeting, 2004 Aug 17; San Diego, Chico, Calif: ASRS; 2004. p. 109.
41. Lindsey P, Finkelstein D, D'Anna S. Experimental retinal relocation [abstract]. Invest Ophthalmol Vis Sci 1983;24 (Suppl 3):242.
42. Machemer R, Steinhorst UH. Retinal separation, retinotomy and macular relocation. I: Experimental studies in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 1993;231: 629-34.
43. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation. II: A surgical approach for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1993;231:635-41.
44. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999;237:313-25.
45. Toth CA, Freedman SF. Macular translocation with 360-degree peripheral retinectomy: impact of technique and surgical experience on visual outcomes. Retina 2001;21:293-303.
46. de Juan E, Lowenstein A, Bressler NM, Alexander J. Translocation of the retina tor management of subfoveal choroidal neovascularization. II: A preliminary report in humans. Am J Ophthalmol 1998;125:635-46.
47. Lewis H. Macular translocation with chorioscleral outfolding: a pilot clinical study. Am J Ophthalmol 2001;132:156-63.
48. Cahill MT, Freedman SH, Toth CA. Macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol 2003;121:132-3.
49. American Academy of Ophthalmology. Macular translocation. Ophthalmology 2000;107:1015-8.
50. Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 2002;120:451-9.
51. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 2002;134:560-5.
52. Lai JC, Lapolice DJ, Stinnett SS, Meyer CH, Arieu LM, Keller MA, et al. Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch Ophthalmol 2002;120:1317-24.
53. Wolf S, Lappas A, Weinbergen AW, Kirchof B. Macular translocation for surgical management of subfoveal choroidal neovascularization in patients with AMD: first results. Graefes Arch Clin Exp Ophthalmol 1999;237:51-7.
54. Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology 2004;111:1715-24.
55. Cahill MT, Stinnett SS, Banks AO, Freedman SF, Toth CA. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology 2005;112:144-51.
56. Oyagi T, Fujikado T, Hosohata J, Ohji M, Kamei M, Bessho K, et al. Foveal sensitivity and fixation stability before and after macular translocation with 360-degree retinotomy. Retina 2004;24:548-55.
57. Ninomiya Y, Lewis JM, Hasegawa T, Tano Y. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Am J Ophthalmol 1996;122:613-21.
58. Ohji M, Fujikado F, Kusaka S, Hayashi A, Hosohata J, Ikuno Y, et al. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol 2001;132:888-96.
59. Toth CA. The debate: extended macular translocation - a useful procedure. In: Proceedings of the AAO - The Retina Debates 2003: New Technology and Controversies in the Posterior Segment [Subspecialty Day at the American Academy of Ophthalmology Annual Meeting]; 2003 Nov 14; Anaheim, Calif. San Francisco: AAO; 2003. p. 201-5.
60. Fujii GY, Pieramici DJ, Humayun MS, Schachat AP, Reynolds SM, Melia M, et al. Complications associated with limited macular translocation. Am J Ophthalmol 2000;130:751-62.
61. Pieramici DJ, de Juan F Jr, Fujii GY, Reynolds SM, Melia M, Humayun MS, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 2000;130:419-28.
62. Kamei M, Tano Y, Yasuhara T, Ohji M, Lewis H. Macular translocation with chorioscleral outfolding: 2-year results. Am J Ophthalmol 2004;138:574-81.
63. Ng FW, Fujii GY, Au Eong KG, Reynolds SM, Melia BM, Kouzis AC, et al. Macular translocation in patients with recurrent subfoveal choroidal neovascularization. Ophthalmology 2004;111:1889-93.
64. Deramo VA, Meyer CH, Toth CA. Successful macular translocation with temporary scleral infolding using absorbable suture. Retina 2001;21:304-11.